Download Full eBooks in PDF
Antipsychotics And Mood Stabilizers Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Antipsychotics And Mood Stabilizers book. This book definitely worth reading, it is an incredibly well-written.
Author : Stephen M. Stahl
Publisher : Cambridge University Press
Page : 23 pages
File Size : 50,7 Mb
Release : 2009-04-27
Category : Medical
ISBN : 9780521759007
This spin-off from Stephen M. Stahl's new, completely updated third edition of his much-acclaimed Prescriber's Guide covers drugs for psychosis and mood disorders.
Author : Stephen M. Stahl
Publisher : Cambridge University Press
Page : 207 pages
File Size : 49,5 Mb
Release : 2008-03-27
Category : Medical
ISBN : 9780521886642
Relying upon the best-selling third edition of Stahl's Essential Psychopharmacology, Dr Stephen M. Stahl has revised chapters covering antipsychotics and mood stabilizers for this edition. More than one-third longer than the previous edition it is essential reading for professionals treating psychosis and students learning the mechanisms of drug reactions. It includes advances in neurobiology and recent clinical developments to explain the concepts underlying drug treatment of psychiatric disorders. The fully revised text is complemented by many new illustrations and enhanced to reflect new knowledge and topics covered in the previous edition. Intended as a primer text covering all aspects of treatment for psychosis and related conditions, this concise volume can nevertheless be read cover to cover by experts and novices alike. Accreditation and Credit Designation Statements The Neuroscience Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Neuroscience Education Institute designates this educational activity for a maximum of 90.0 AMA PRA Category 1 Credits(tm). Physicians should only claim credit commensurate with the extent of their participation in the activity. Sponsorship Information Sponsored by Neuroscience Education Institute Support This activity is supported solely by the sponsor. Neither the Neuroscience Education Institute nor Stephen M. Stahl, MD, PhD has received any funds or grants in support of this educational activity.
Author : Stephen M. Stahl
Publisher : Cambridge University Press
Page : 164 pages
File Size : 44,6 Mb
Release : 2002-05-27
Category : Medical
ISBN : 0521890748
Drawn from the best-selling second edition of Essential Psychopharmacology, in this revised and updated new book Steve Stahl covers the many dimensions of psychosis (causes, pathophysiology, treatment and the role of dopamine). New material includes discussion of a promising new agent, aripiprazole, the first in a new class of dopamine stabilizers; the use of anticonvulsant agents; and the newest atypical antipsychotic ziprasidone. This book will be essential reading for all professionals treating psychosis, and students who need to know the mechanisms of drug actions. CME self-assessment tests are included.
Author : Gerhard Gross,Mark A. Geyer
Publisher : Springer
Page : 0 pages
File Size : 50,5 Mb
Release : 2014-12-14
Category : Medical
ISBN : 3642445470
Six decades after the serendipitous discovery of chlorpromazine as an antipsychotic and four decades after the launch of clozapine, the first atypical or second generation antipsychotic, psychopharmacology has arrived at an important crossroad. It is clear that pharmacological research and pharmaceutical development must now focus on complementary or even alternative mechanisms of action to address unmet medical needs, i.e. poorly treated domains of schizophrenia, improved acceptance by patients, better adherence to medication, safety in psychoses in demented patients, and avoiding cardiac and metabolic adverse effects. The first completely novel mechanisms evolving from our insights into the pathophysiology of psychotic disorders, especially the role of glutamatergic mechanisms in schizophrenia, are now under development, and further principles are on the horizon. This situation, in many respects similar to that when the initial second-generation antipsychotics became available, can be rewarding for all. Preclinical and clinical researchers now have the opportunity to confirm their hypotheses and the pharmaceutical industry may be able to develop really novel classes of therapeutics. When we were approached by the publishers of the Handbook of Experimental Pharmacology to prepare a new volume on antipsychotics, our intention was to capture both, the accumulated preclinical and clinical knowledge about current antipsychotics as well as prospects for new and potentially more specific antischizophrenia principles. These efforts should be based on the pathophysiology of the diseases and the affected neurotransmitter systems. Since preclinical research on antipsychotic compounds is only reliable when intimately linked through translational aspects to clinical results, we decided to include clinical science as well. It turned out that that this endeavor could not be covered by a single volume. We thank the editorial board and the publishers for supporting our decision to prepare two volumes: Current Antipsychotics and Novel Antischizophrenia Treatments. These topics cannot really be separated from one another and should be seen as a composite entity despite the somewhat arbitrary separation of contributions into two volumes. The continuing challenges of developing improved and safer antipsychotic medications remain of concern and are discussed in the first volume. The new opportunities for the field to develop and license adjunctive treatments for the negative symptoms and cognitive deficits that are treated inadequately by existing compounds have been incentivized recently and provide the focus for the second volume. We hope these collective contributions will facilitate the development of improved treatments for the full range of symptomatology seen in the group of schizophrenias and other major psychotic disorders. Gerhard Gross, Ludwigshafen, Germany Mark A. Geyer, La Jolla, CA This volume will try to put current therapy - achievements, shortcomings, remaining medical needs - and emerging new targets into the context of increasing knowledge regarding the genetic and neurodevelopmental contributions to the pathophysiology of schizophrenia. Some of the chapters will also deal with respective experimental and clinical methodology, biomarkers, and translational aspects of drug development. Non-schizophrenia indications will be covered to some extent, but not exhaustively.
Author : Stephen M. Stahl
Publisher : Cambridge University Press
Page : 145 pages
File Size : 49,5 Mb
Release : 2006-05-29
Category : Medical
ISBN : 9780521616355
This is a pragmatic, easy-to-use formulary for prescribing clinicians, covering the main antipsychotic and mood stabilization drugs.
Author : Peter Riederer,Gerd Laux,Toshiharu Nagatsu,Weidong Le,Christian Riederer
Publisher : Springer Nature
Page : 4652 pages
File Size : 55,5 Mb
Release : 2022-11-04
Category : Medical
ISBN : 9783030620592
This book provides a reference guide describing the current status of medication in all major psychiatric and neurological indications, together with comparisons of pharmacological treatment strategies in clinical settings in Europe, USA, Japan and China. In addition, it highlights herbal medicine as used in China and Japan, as well as complementary medicine and nutritional aspects. This novel approach offers international readers a global approach in a single dedicated publication and is also a valuable resource for anyone interested in comparing treatments for psychiatric disorders in three different cultural areas. There are three volumes devoted to Basic Principles and General Aspects, offering a general overview of psychopharmacotherapy (Vol. 1); Classes, Drugs and Special Aspects covering the role of psychotropic drugs in the field of psychiatry and neurology (Vol. 2) and Applied Psychopharmacotherapy focusing on applied psychopharmacotherapy (Vol. 3). These books are invaluable to psychiatrists, neurologists, neuroscientists, medical practitioners and clinical psychologists.
Author : D.E. Casey,T.N. Chase,A.V. Christensen,J. Gerlach
Publisher : Springer Science & Business Media
Page : 230 pages
File Size : 51,6 Mb
Release : 2013-03-12
Category : Medical
ISBN : 9783642701405
Papers Presented at an International Symposium, Held in 1984 at Kollekolle, Denmark
Author : American Psychiatric Association
Publisher : American Psychiatric Pub
Page : 60 pages
File Size : 49,6 Mb
Release : 2002
Category : Medical
ISBN : 0890423229
The book provides treatment recommendations for bipolar patients, a review of evidence about bipolar disorder, and states research needs
Author : Chris Aiken,Joshua D. Feder,Daniel J. Carlat
Publisher : Unknown
Page : 226 pages
File Size : 45,6 Mb
Release : 2021-10
Category : Medical
ISBN : 1732952264
Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them. The book also includes a series of unusually practical charts and tables that prescribers will find invaluable as they make medication decisions. What you'll find inside: The basics of drug metabolism What you really need to know about drug interactions Food and drink effects on medications Recreational drug interactions Gender and drug metabolism Drug metabolism and ethnicity More than 70 quick-reference tables, charts, and figures
Author : Katherine J. Aitchison,Robin M. Murray,Patrick J. Power,Eva M. Tsapakis
Publisher : CRC Press
Page : 152 pages
File Size : 51,5 Mb
Release : 2022-03-26
Category : Medical
ISBN : 9780429524141
The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management. This is an authoritative text written by a team of highly respected authors for psychiatrists, neurologists, primary care practitioners and health care professional working in psychiatry. Drawing from their experience, the presentation and assessment of the first psychotic episode are discussed, details regarding antipsychotic drugs and their appropriate use are reviewed and psychosocial approaches are examined. The resulting book offers a concise and valuable guide to those wishing to review the latest proposals for the treatment of first-episode psychosis supported by up-to-date references, in a single publication.
Author : Stephen M. Stahl
Publisher : Cambridge University Press
Page : 167 pages
File Size : 42,9 Mb
Release : 2009-04-13
Category : Medical
ISBN : 9781139833004
All of the titles in the Stahl's Illustrated series are designed to be fun. Concepts are illustrated by full-color images that will be familiar to all readers of Stahl's Essential Psychopharmacology, 3rd Edition and The Prescriber's Guide. The visual learner will find that these books make psychopharmacology concepts easy to master, while the non-visual learner will enjoy a shortened text version of complex psychopharmacology concepts. Within each book, each chapter builds on previous chapters, synthesizing information from basic biology and diagnostics to building treatment plans and dealing with complications and comorbidities. Novices may want to approach Stahl's Illustrated series by first looking through all the graphics and gaining a feel for the visual vocabulary. Readers more familiar with these topics should find that going back and forth between images and text provides an interaction with which to vividly conceptualize complex pharmacologies. And, to help guide the reader toward more in-depth learning about particular concepts, each book ends with a Suggested Reading section.
Author : Peter Haddad,Tim Lambert,John Lauriello
Publisher : Oxford University Press
Page : 320 pages
File Size : 49,8 Mb
Release : 2016-05-10
Category : Medical
ISBN : 9780191045783
Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Since the initial publication of Antipsychotic Long-acting Injections in 2010, new trial data have been published on long-acting injection (LAI) preparations of the drugs Risperidone, Paliperidone, and Olanzapine. Furthermore, a new LAI preparation of the drug Aripiprazole has recently been approved for clinical use in the United States and is likely to be approved in Europe soon. The second edition of this successful book has been fully updated to include this new data, with reference to both observational studies and randomized controlled trials, as well as other new developments in the clinical use of antipsychotic LAIs. New chapters have been added covering the comparison between oral and injectable antipsychotics, Olanzapine LAI, Aripiprazole LAI, and the practicalities of organizing a specialized clinic for long-acting injectable antipsychotics. Existing chapters have also been thoroughly updated to take into account the most recently published research. Antipsychotic Long-acting Injections, Second edition brings together clinical and research findings on LAIs in a comprehensive volume, with chapters written by international experts.
Author : Stephen Stahl
Publisher : Cambridge University Press
Page : 646 pages
File Size : 45,9 Mb
Release : 2009-04-27
Category : Medical
ISBN : 9780521743990
This completely revised and updated edition of Stephen M. Stahl's much-acclaimed Prescriber's Guide is the latest addition to the Essential Psychopharmacology range. Seven new drugs have been added, and every drug has been revised and updated to take into account new regulations and uses. In full color throughout, and with four or more pages for each of the more than 100 psychotropic drugs, Stephen M. Stahl distills his great expertise into a pragmatic formulary that gives all the information a prescriber needs to treat patients effectively. Each drug is covered in five categories: general therapeutics, dosing and use, side effects, special populations, and pearls. Target icons appear next to key categories for each drug so the prescriber can go easily and instantly to the information needed. Several indices are included, listing drugs by name (generic and international), use, and class. In addition, Dr. Stahl indicates which drugs have FDA approval and also gives the FDA Use-in-Pregnancy Ratings.
Author : Basant K. Puri
Publisher : OUP Oxford
Page : 240 pages
File Size : 55,9 Mb
Release : 2013-02-28
Category : Medical
ISBN : 9780191649271
Part of the Drugs in series, the updated second edition of this practical pocketbook summarizes essential information on all the major drugs currently used in clinical psychiatric practice. Beginning with a brief discussion on drugs in psychiatry, the text moves on to consider the principles of psychopharmacology, which form the foundation of the sound, scientifically based use of drugs in psychiatry. Details are then given, in turn, of the main non-depot antipsychotic drugs, antipsychotic depot injections, antimanic drugs, tricyclic and related antidepressant drugs, monoamine-oxidase inhibitors, selective serotonin re-uptake inhibitors, and other antidepressants. This practical pocketbook is an essential companion for all medical staff involved in psychopharmacology, both for learning and quick reference.
Author : Anastasios Georgotas,Robert Cancro
Publisher : Unknown
Page : 674 pages
File Size : 55,9 Mb
Release : 1988
Category : Affective disorders
ISBN : UOM:39015036217282
